ExploreWatchlistsPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Cash from investing

KISSEI PHARMACEUTICAL CO.,LTD. (4547)

Market cap
¥192.1B
P/E ratio
11.2x
Kissei Pharmaceutical develops and manufactures prescription drugs while also operating subsidiaries in food products, IT services, and construction.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 202617,500+253.39%
Mar 31, 20254,952-43.01%
Mar 31, 20248,690+44.81%
Mar 31, 20236,001-44.31%
Mar 31, 202210,776-215.51%
Mar 31, 2021-9,329-2003.88%
Mar 31, 2020490-123.48%
Mar 31, 2019-2,087-29.47%
Mar 31, 2018-2,959-36.65%
Mar 31, 2017-4,671-17.84%
Mar 31, 2016-5,685+79.45%
Mar 31, 2015-3,168

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat